Description

GHRP-2 – 10 mg

(Growth Hormone Releasing Peptide-2)

GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic hexapeptide belonging to the ghrelin mimetic family, designed to stimulate the release of endogenous growth hormone (GH) through activation of the ghrelin receptor (GHS-R1a). It functions independently of the hypothalamic GHRH pathway, providing a direct and potent stimulus to the pituitary gland to promote pulsatile GH secretion in research models.

Extensively studied in both animal and early human research, GHRP-2 has been evaluated for its potential roles in metabolism, muscle growth, cellular regeneration, and immune modulation.

---

Mechanism of Action (Based on Preclinical and Clinical Research):

• Ghrelin receptor activation: Binds to and activates GHS-R1a, mimicking the natural ligand ghrelin to stimulate GH release.

• Pituitary stimulation: Induces growth hormone secretion through both hypothalamic and pituitary pathways.

• Synergistic interaction: Demonstrates additive effects when combined with GHRH analogs such as CJC-1295.

• Metabolic regulation: Enhances protein synthesis, supports lipid metabolism, and may increase appetite in experimental models.

• Neuroendocrine influence: Modulates stress, energy balance, and sleep patterns in research settings.

---

Potential Benefits (Based on Preclinical Research):

• Increased pulsatile growth hormone and IGF-1 levels

• Enhanced muscle recovery and protein synthesis

• Improved lipid utilization and body-composition regulation

• Investigated for anti-aging and regenerative-biology models

• Synergistic applications with other GH secretagogues (e.g., CJC-1295, GHRP-6)

---

For Research Use Only. Not for Human Consumption.
This compound is not approved by the FDA or any regulatory agency and is intended solely for laboratory research.